Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential mechanism of purinergic receptor-mediated remyelination discovered

Aug. 6, 2018

DrugCendR recruiting participants for phase I study of CEND-1 in metastatic pancreatic cancer

Aug. 6, 2018

IL-23 underlies the development of castration-resistant prostate cancer

Aug. 6, 2018

Immatics begins phase I study of IMA-202 in solid tumors

Aug. 6, 2018

Salix enters microbiome collaboration with Cedars-Sinai Medical Center

Aug. 6, 2018

HitGen to identify potential new therapies for tuberculosis and malaria

Aug. 6, 2018

JCR Pharmaceuticals presents data for JR-141 in mucopolysaccharidosis type II

Aug. 6, 2018

Neurodegenerative differences found between the presubiculum and entorhinal cortex in AD

Aug. 6, 2018

Medicenna's IL-2 superkine shows promising preclinical activity

Aug. 6, 2018

Enzyme discovery may improve drug design

Aug. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...